CareDx, Inc.
CDNANasdaqCIK 1217234HealthcareFiscal year ends Dec 31
Reports and events: 255 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-04-2015:49 ET | DEF 14A | Proxy statementPeriod 2020-12-31 | 0001217234-21-000072 |
| 2021-03-1116:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-077777 |
| 2021-02-2417:03 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001217234-21-000046 |
| 2021-02-2416:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001217234-21-000044 |
| 2021-01-2116:56 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-013618 |
| 2021-01-1107:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001217234-21-000016 |
| 2020-12-1016:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-20-314849 |
| 2020-10-2917:11 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001217234-20-000192 |
| 2020-10-2916:13 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-281060 |
| 2020-10-0716:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001217234-20-000182 |
| 2020-08-0417:07 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001217234-20-000146 |
| 2020-08-0416:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001217234-20-000144 |
| 2020-06-2416:54 ET | 8-K/A | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001217234-20-000111 |
| 2020-06-2318:28 ET | 8-K | 5.07 Shareholder vote results | 0001217234-20-000106 |
| 2020-06-1116:02 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-166621 |
| 2020-06-1016:02 ET | 8-K/A | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-20-165663 |
| 2020-06-0916:03 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-20-164630 |
| 2020-04-3017:14 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001217234-20-000057 |
| 2020-04-3016:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001217234-20-000055 |
| 2020-04-2912:29 ET | DEF 14A | Proxy statementPeriod 2019-12-31 | 0001217234-20-000049 |
| 2020-04-0816:46 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-101431 |
| 2020-02-2817:36 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001217234-20-000033 |
| 2020-02-2716:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001217234-20-000030 |
| 2020-01-1306:50 ET | 8-K | 2.02 Results of operations | 0001628280-20-000301 |
| 2019-10-3117:28 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001628280-19-012991 |
| 2019-10-3116:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-19-012965 |
| 2019-09-0416:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-19-237752 |
| 2019-08-2806:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-19-231262 |
| 2019-08-0116:54 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001564590-19-028018 |
| 2019-08-0116:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-19-210798 |
| 2019-07-0506:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-19-189407 |
| 2019-06-1819:25 ET | 8-K | 5.07 Shareholder vote results | 0001193125-19-174982 |
| 2019-05-0817:11 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001564590-19-017322 |
| 2019-05-0816:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-19-141372 |
| 2019-04-3009:47 ET | DEF 14A | Proxy statementPeriod 2019-06-17 | 0001193125-19-127697 |
| 2019-04-2617:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-19-119996 |
| 2019-04-1011:58 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-19-102545 |
| 2019-03-2612:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-19-086284 |
| 2019-03-0617:22 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001564590-19-006533 |
| 2019-03-0616:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-19-065556 |
| 2019-01-0708:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-19-003188 |
| 2018-12-1716:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-18-350985 |
| 2018-11-2616:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-18-333933 |
| 2018-11-2608:00 ET | 8-K | 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-18-333417 |
| 2018-11-1616:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-18-328950 |
| 2018-11-1406:17 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-18-326068 |
| 2018-11-0816:52 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001564590-18-028612 |
| 2018-11-0816:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-18-322510 |
| 2018-10-0913:09 ET | 10-Q/A | Quarterly report, amendedPeriod 2018-06-30 | 0001564590-18-024071 |
| 2018-08-3117:24 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-18-265141 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:18 ET. Listed shows no prices and gives no investment advice.